Trade Ideas Finds Your Next Trade in Editas Medicine, Inc.

WEDNESDAY

EDIT

Editas Medicine, Inc.

SCoRE: 43

LAST PRICE - AT THE CLOSE

EDIT is DOWN -50% since the begininning of the year

EDIT is DOWN -11% BELOW 20 day SMA

EDIT is DOWN -39% BELOW 200 day SMA

PROFITABLE: NO
EPS: $-0.23

EARNINGS MOMENTUM: YES
0.63% INCREASE IN QTRLY EARNINGS

P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00

REVENUE IS: 78M

DEBT IS: 37K

CASH IS: 323M

	THE STOCK IS 95.0% AWAY FROM ALL-TIME HIGHS OF $99.95
	EDIT IS DOWN -50% SINCE THE BEGINNING OF THE YEAR
	EDIT IS DOWN -48% OVER THE PAST 12 MONTHS
	EDIT IS DOWN -28% OVER THE PAST 1 MONTH
	25% OF ALL EDIT INVESTORS ARE BETTING AGAINST EDIT
	NUM INVESTORS SHORT EDIT HAS GONE UP N/A% VERSUS LAST MONTH